We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 13

EU political update 4 - 8 March 2013

  • Clifford Chance LLP
  • -
  • China, European Union, Germany, Global, Peru, Portugal
  • -
  • March 4 2013

On 27 February, the European Commission decided under the EU Merger Regulation to prohibit the third attempt of low-cost airline Ryanair to acquire

Antitrust review January - February 2011

  • Clifford Chance LLP
  • -
  • China, Czech Republic, European Union, France, Germany, Poland, Romania, Slovakia, Spain, United Kingdom, USA
  • -
  • March 11 2011

The European Commission (the Commission) has prohibited the proposed merger between Aegean Airlines (Aegean) and Olympic Air (Olympic) (the proposed transaction

Antitrust review May - June 2011

  • Clifford Chance LLP
  • -
  • China, Czech Republic, European Union, France, Germany, Poland, Romania, Spain, United Kingdom
  • -
  • July 15 2011

The European Commission (the Commission) has published a set of draft "best practices" for cooperation among national competition authorities within the EU (NCAs) for mergers that are not subject to EU merger control but require clearance in several Member States (best practices

Recent developments for the fourth quarter 2011

  • Baker & McKenzie
  • -
  • Canada, China, Denmark, European Union, France, Germany, Ireland, Italy, Japan, Netherlands, Switzerland, United Kingdom, USA
  • -
  • March 15 2012

The end of the year and beginning of a new year is always a busy time for us, as it is for most of our clients

International labour law bulletin - Summer 2012

  • Freshfields Bruckhaus Deringer LLP
  • -
  • Belgium, China, European Union, Germany, Italy, Netherlands, United Kingdom
  • -
  • September 5 2012

A round-up of developments in international employment law over the past quarter

General counsel update

  • Herbert Smith Freehills LLP
  • -
  • China, European Union, Germany, Hong Kong, Indonesia, Mongolia, Singapore, United Kingdom, USA
  • -
  • July 11 2012

This is the thirtieth in our series of general counsel updates which aim to summarise major developments in key areas

Transmit - April 2013

  • CMS Cameron McKenna
  • -
  • China, Czech Republic, European Union, Germany, Global, Hungary, Italy, Russia, Slovenia, Spain, Switzerland, Ukraine, United Kingdom, USA
  • -
  • April 30 2013

On 20 February 2013, Ofcom announced the five winning bidders to deliver 4G services in the UK. After more than 50 rounds of bidding, Everything

Insurance review Winter 20122013

  • Clifford Chance LLP
  • -
  • China, European Union, France, Germany, Hong Kong, Italy, Spain, United Kingdom, USA
  • -
  • April 17 2013

On 20 February 2013 it was announced that the European Parliament will now not consider Omnibus II until its 21-24 October 2013 plenary session, four

Consumer goods and retail industry competition bulletin

  • Clifford Chance LLP
  • -
  • Belgium, China, European Union, Germany, Italy, United Kingdom, USA
  • -
  • September 29 2011

This edition of the Consumer Goods and Retail Industry Competition Bulletin includes details of China's recent imposition of fines in relation to a price rise announcement, a review of the OFT's practice of requiring an upfront buyer as part of a divestiture remedy, and a summary of the OFT's findings following its 7-year dairy products investigation

Updates on international pricing issues for pharmaceutical and biologic products

  • Sidley Austin LLP
  • -
  • China, European Union, France, Germany, United Kingdom, USA
  • -
  • May 18 2012

Sidley Austin LLP’s Global Life Sciences Team is pleased to provide you with this Global Pricing Newsletter, the first in a periodic series updating clients and friends of the firm on pricing issues around the world that may have an impact on pharmaceutical and biologic manufacturers’ legal and business strategies